Evidence map›Paper›PMID 36292720›Full record

ArticleGenes2022

Clinical, Biochemical, and Molecular Characterization of Two Families with Novel Mutations in the

Pablo Serrano-Lorenzo, María Rabasa, Jesús Esteban, Irene Hidalgo Mayoral, Cristina Domínguez-González, Agustín Blanco-Echevarría, Rocío Garrido-Moraga, Alejandro Lucia, Alberto Blázquez, Juan C Rubio and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Glycogen storage diseases.Nature reviews. Disease primers · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Pablo Serrano-LorenzoMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.ORCID 0000-0002-5661-7574
María RabasaNeurology Department, Hospital de Fuenlabrada, 28942 Madrid, Spain.
Jesús EstebanNeuromuscular Unit, Department of Neurology, 12 de Octubre University Hospital, 28041 Madrid, Spain.
Irene Hidalgo MayoralMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.ORCID 0000-0002-9104-4767
Cristina Domínguez-GonzálezMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.ORCID 0000-0001-5151-988X
Agustín Blanco-EchevarríaDepartment of Internal Medicine, 12 de Octubre University Hospital, 28041 Madrid, Spain.
Rocío Garrido-MoragaMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.ORCID 0000-0002-2856-4399
Alejandro LuciaMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
Alberto BlázquezMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.ORCID 0000-0002-6479-3615
Juan C RubioMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
Carmen Palma-MillaDepartment of Genetics, 12 de Octubre University Hospital, 28041 Madrid, Spain.ORCID 0000-0002-1718-4390
Joaquín ArenasMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
Miguel A MartínMitochondrial and Neuromuscular Disorders Group, Hospital 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.ORCID 0000-0003-4741-772X
Research Institute Hospital 12 de Octubre · ESHospital Universitario de Fuenlabrada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactate dehydrogenase (LDH) catalyzes the reversible conversion of L-lactate to pyruvate. LDH-A deficiency is an autosomal recessive disorder (glycogenosis type XI, OMIM#612933) caused by mutations in the LDHA gene. We present two young adult female patients presenting with intolerance to anaerobic exercise, episodes of rhabdomyolysis, and, in one of the patients, psoriasis-like dermatitis. We identified in the LDHA gene a homozygous c.410C>A substitution that predicts a p.Ser137Ter nonsense mutation in Patient One and a compound heterozygous c.410C>A (p.Ser137Ter) and c.750G>A (p.Trp250Ter) nonsense mutation in Patient Two. The pathogenicity of the variants was demonstrated by electrophoretic separation of LDH isoenzymes. Moreover, a flat lactate curve on the forearm exercise test, along with the clinical combination of myopathy and psoriatic-like dermatitis, can also lead to the diagnosis.

Indexed as

DermatitisGlycogen Storage DiseaseCodon, NonsenseFemaleHumansIsoenzymesLactate Dehydrogenase 5Lactic AcidL-Lactate DehydrogenaseMutationPyruvic AcidCodon, NonsenseIsoenzymesLactate Dehydrogenase 5Lactic AcidL-Lactate DehydrogenasePyruvic Acidlactate dehydrogenase A deficiencylactate dehydrogenase (LDH)LDHA geneLDH isoenzymesmyopathy and psoriatic dermatitis

Identifiers

PMID36292720
PMCPMC9601687
OpenAlexW4304585226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.